| # | Drug | Count |
|---|---|---|
| 0 | BORTEZOMIB | 765 |
| 1 | DEXAMETHASONE | 675 |
| 2 | DEXAMETHASONE 1.5 MG | 675 |
| 3 | LENALIDOMIDE | 651 |
| 4 | DARATUMUMAB | 515 |
| 5 | CARFILZOMIB | 472 |
| 6 | POMALIDOMIDE | 376 |
| 7 | CYCLOPHOSPHAMIDE | 294 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 294 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 294 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELRANATAMAB-BCMM | 20 | 0.0173 |
| 1 | CARFILZOMIB | 472 | 0.0166 |
| 2 | PLATINUM | 8 | 0.0151 |
| 3 | ISATUXIMAB | 86 | 0.0148 |
| 4 | BELANTAMAB MAFODOTIN | 36 | 0.0116 |
| 5 | ELOTUZUMAB | 47 | 0.0091 |
| 6 | BORTEZOMIB | 765 | 0.0085 |
| 7 | SELINEXOR | 65 | 0.0074 |
| 8 | IBERDOMIDE | 1 | 0.0067 |
| 9 | CALCIFEDIOL | 17 | 0.0067 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 573 | 0.0979 |
| 1 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 47 | 0.0091 |
| 2 | Proteasome Inhibitor [EPC] | 919 | 0.0080 |
| 3 | Nuclear Export Inhibitor [EPC] | 65 | 0.0074 |
| 4 | Endoglycosidase [EPC] | 5 | 0.0027 |
| 5 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 3 | 0.0024 |
| 6 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 7 | Thalidomide Analog [EPC] | 752 | 0.0014 |
| 8 | Topoisomerase Inhibitor [EPC] | 99 | 0.0013 |
| 9 | Alkylating Drug [EPC] | 296 | 0.0012 |